DATTOLA, Annunziata et al. Evaluating the Efficacy of Bimekizumab Across Different Sensitive Areas in Moderate-to-Severe Psoriasis: 52-week Multicentric Real-Life Experience in Lazio, Italy. Dermatology Practical & Conceptual, [S. l.], v. 15, n. 2, p. 4976 , 2025. DOI: 10.5826/dpc.1502a4976. Disponível em: https://dpcj.org/index.php/dpc/article/view/4976.. Acesso em: 20 apr. 2026.